POCI director awarded 30,000 stock options at $4.33

Precision Optics Corporation, Inc. (POCI) reported an insider equity award for a director.

Rhea-AI Filing Summary

Precision Optics Corporation, Inc. (POCI) reported an insider equity award for a director. The filing shows a grant of stock options, which are rights to buy common stock in the future at a fixed price.

The director received 30,000 stock options with an exercise price of $4.33 per share, becoming exercisable over time. According to the filing, these options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, as long as the director remains in continuous employment with the company through each vesting date. The options were granted under the company’s 2022 Equity Incentive Plan and are scheduled to expire on November 17, 2035.

Insider Trade Summary

Grant/Award: 30,000 shares

Grant/Award 1 txn

Insider Miclot Andrew J.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (Rights to buy)	30,000	$0.00	$0.00

Holdings After Transaction: Stock Options (Rights to buy) — 30,000 contracts (Direct)

Footnotes (1)

1. F1. The options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, subject to the reporting person remaining in the continuous employment of the Issuer through such applicable date. The options were granted under the Precision Optics Corporation, Inc. 2022 Equity Incentive Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did POCI report in this Form 4?

The company reported a grant of 30,000 stock options to a director, giving the right to purchase POCI common stock at a fixed exercise price.

What is the exercise price of the new POCI stock options?

The stock options have an exercise price of $4.33 per share, as disclosed in the filing.

When do the newly granted POCI stock options vest?

The options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, subject to continuous employment.

When do the reported POCI stock options expire?

The filing states that the stock options expire on November 17, 2035 if not exercised earlier.

Under which plan were the POCI stock options granted?

The options were granted under the Precision Optics Corporation, Inc. 2022 Equity Incentive Plan.

Is the reporting person a director of POCI?

Yes. The form identifies the reporting person’s relationship to Precision Optics Corporation, Inc. as a Director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/19/2025 - 04:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Miclot Andrew J.

(Last) (First) (Middle)

C/O PRECISION OPTICS CORPORATION, INC.

22 EAST BROADWAY

(Street)

GARDNER MA 01440

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PRECISION OPTICS CORPORATION, INC. [ POCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Rights to buy)	$4.33	11/17/2025		A		30,000		(1)	11/17/2035	Common Stock	30,000	$0	30,000	D

Explanation of Responses:

1. The options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, subject to the reporting person remaining in the continuous employment of the Issuer through such applicable date. The options were granted under the Precision Optics Corporation, Inc. 2022 Equity Incentive Plan.

	/s/ Joseph N. Forkey as attorney-in-fact	11/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.